Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 Variants.

GBA associated Parkinson’s disease LRRK2 associated Parkinson’s disease Parkinson’s disease environmental exposure pesticide exposure

Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
28 May 2024
Historique:
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 31 5 2024
Statut: aheadofprint

Résumé

The penetrance of common genetic risk variants for Parkinson's disease (PD) is low. Pesticide exposure increases PD risk, but how exposure affects penetrance is not well understood. To determine the relationship between occupational pesticide exposure and PD in people with LRRK2 and GBA risk variants. Participants of the Parkinson's Progression Markers Initiative (PPMI) with a LRRK2-G2019 S or GBA risk variant provided information about occupational pesticide exposure. We compared exposure in carriers with and without PD. Among carriers with PD, we used Cox proportional hazard models to compare time-to impairment in balance, cognition, and activities of daily living (ADLs) between participants with and without prior occupational pesticide exposure. 378 participants with a risk variant provided exposure information; 176 with LRRK2-G2019 S (54 with and 122 without PD) and 202 with GBA variants (47 with and 155 without PD). Twenty-six participants reported pesticide exposure. People with a GBA variant and occupational pesticide exposure had much higher odds of PD (aOR: 5.4, 95% CI 1.7-18.5, p < 0.01). People with a LRRK2 variant and a history of occupational pesticide exposure had non-significantly elevated odds of PD (aOR 1.3, 95% CI 0.4-4.6, p = 0.7). Among those with PD, pesticide exposure was associated with a higher risk of balance problems and cognitive impairment in LRRK2-PD and functional impairment in GBA-PD, although associations were not statistically significant. Occupational pesticide exposure may increase penetrance of GBA-PD and may be associated with faster symptom progression. Further studies in larger cohorts are necessary.

Sections du résumé

Background UNASSIGNED
The penetrance of common genetic risk variants for Parkinson's disease (PD) is low. Pesticide exposure increases PD risk, but how exposure affects penetrance is not well understood.
Objective UNASSIGNED
To determine the relationship between occupational pesticide exposure and PD in people with LRRK2 and GBA risk variants.
Methods UNASSIGNED
Participants of the Parkinson's Progression Markers Initiative (PPMI) with a LRRK2-G2019 S or GBA risk variant provided information about occupational pesticide exposure. We compared exposure in carriers with and without PD. Among carriers with PD, we used Cox proportional hazard models to compare time-to impairment in balance, cognition, and activities of daily living (ADLs) between participants with and without prior occupational pesticide exposure.
Results UNASSIGNED
378 participants with a risk variant provided exposure information; 176 with LRRK2-G2019 S (54 with and 122 without PD) and 202 with GBA variants (47 with and 155 without PD). Twenty-six participants reported pesticide exposure. People with a GBA variant and occupational pesticide exposure had much higher odds of PD (aOR: 5.4, 95% CI 1.7-18.5, p < 0.01). People with a LRRK2 variant and a history of occupational pesticide exposure had non-significantly elevated odds of PD (aOR 1.3, 95% CI 0.4-4.6, p = 0.7). Among those with PD, pesticide exposure was associated with a higher risk of balance problems and cognitive impairment in LRRK2-PD and functional impairment in GBA-PD, although associations were not statistically significant.
Conclusions UNASSIGNED
Occupational pesticide exposure may increase penetrance of GBA-PD and may be associated with faster symptom progression. Further studies in larger cohorts are necessary.

Identifiants

pubmed: 38820021
pii: JPD240015
doi: 10.3233/JPD-240015
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ethan G Brown (EG)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Samuel M Goldman (SM)

Division of Occupational, Environmental, and Climate Medicine, University of California San Francisco, San Francisco, CA, USA.

Christopher S Coffey (CS)

Department of Biostatistics, University of Iowa, Iowa City, IA, USA.

Andrew Siderowf (A)

Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.

Tanya Simuni (T)

Department of Neurology, Northwestern University, Evanston, IL, USA.

Cheryl Meng (C)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Michael C Brumm (MC)

Department of Biostatistics, University of Iowa, Iowa City, IA, USA.

Chelsea Caspell-Garcia (C)

Department of Biostatistics, University of Iowa, Iowa City, IA, USA.

Kenneth Marek (K)

Institute for Neurodegenerative Disorders, New Haven, CT, USA.

Caroline M Tanner (CM)

Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Classifications MeSH